What factors are causing the increased time-to-market for Syneos Health's regulatory submission services in Europe this year?

Introduction

The increased time-to-market for Syneos Health's regulatory submission services in Europe this year is a critical issue that demands immediate attention. To address this problem, I'll employ a systematic approach to identify, validate, and resolve the root cause while considering both short-term and long-term implications.

Step 1

Clarifying Questions (3 minutes)

• Considering the specificity of the issue, I'm wondering about the extent of the delay. Has the time-to-market increased across all regulatory submission services or only for specific types?

Why it matters: This helps narrow down the scope of the problem and identify potential patterns. Expected answer: The increase is primarily in complex submissions for novel therapies. Impact on approach: If limited to specific types, we'd focus on those particular processes.

• Given the European focus, I'm curious about recent regulatory changes. Have there been any significant updates to EU regulatory requirements in the past year?

Why it matters: Regulatory changes could directly impact submission timelines. Expected answer: Yes, there have been updates to clinical trial data requirements. Impact on approach: If confirmed, we'd need to assess our adaptation to these changes.

• Thinking about internal processes, has Syneos Health implemented any new technologies or workflows in the regulatory submission process recently?

Why it matters: New systems often have teething problems that could affect efficiency. Expected answer: A new document management system was introduced six months ago. Impact on approach: If true, we'd investigate the system's impact on submission timelines.

• Considering resource allocation, has there been any significant change in the workload or staffing levels in the European regulatory affairs team?

Why it matters: Resource constraints could lead to bottlenecks and delays. Expected answer: The team size has remained stable, but the number of projects has increased. Impact on approach: If confirmed, we'd look into resource optimization and capacity planning.